Media Summary: Thomas Cluzeau, MD, PhD, University Hospital of Nice, Nice, France, briefly discusses the current role of measurable residual ... Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, highlights challenges with implementing measurable ... Recorded on September 14th, 2023 as part of the Adult

Mrd In Aml Clinical Practice - Detailed Analysis & Overview

Thomas Cluzeau, MD, PhD, University Hospital of Nice, Nice, France, briefly discusses the current role of measurable residual ... Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, highlights challenges with implementing measurable ... Recorded on September 14th, 2023 as part of the Adult Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the In this video, Gail Roboz, MD, Weill Cornell Medicine, New York City, NY, discusses the ongoing use of measurable residual ... Prof. Christopher S. Hourigan DM DPhil FACP FRCP Chief, Laboratory of Myeloid Malignancies National Heart, Lung and Blood ...

Sarah Holstein, MD, PhD, University of Nebraska Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the value of ... In this video, Francesco Buccisano, MD, University of Rome Tor Vergata, Rome, Italy, briefly comments on the role of measurable ... Christopher Hourigan, MD, DPhil, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, reflects on ... During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, KNOW In this video, Francesco Buccisano, MD, University of Rome Tor Vergata, Rome, Italy, provides insight into the recently updated ...

Earn CME for related activities: In this webcast from the '

Photo Gallery

MRD in AML clinical practice
The current role of MRD in AML and challenges with implementing this in clinical practice
Implementing MRD in clinical practice for patients with intermediate-risk AML
What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML
Methods to evaluate MRD in AML
MRD assessment in AML: challenges and evolving clinical impact
MRD Assessment and its Clinical Implications in AML
Clinical Use of Molecular MRD Testing in AML
Know AML | Measurable Residual Disease
Measurable Residual Disease in Acute Myeloid Leukemia MRD in AML
Translating MRD assessment into routine clinical practice
The clinical application of MRD testing in AML
View Detailed Profile
MRD in AML clinical practice

MRD in AML clinical practice

Measurable residual disease (

The current role of MRD in AML and challenges with implementing this in clinical practice

The current role of MRD in AML and challenges with implementing this in clinical practice

Thomas Cluzeau, MD, PhD, University Hospital of Nice, Nice, France, briefly discusses the current role of measurable residual ...

Implementing MRD in clinical practice for patients with intermediate-risk AML

Implementing MRD in clinical practice for patients with intermediate-risk AML

Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, highlights challenges with implementing measurable ...

What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML

What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML

Recorded on September 14th, 2023 as part of the Adult

Methods to evaluate MRD in AML

Methods to evaluate MRD in AML

Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the

MRD assessment in AML: challenges and evolving clinical impact

MRD assessment in AML: challenges and evolving clinical impact

In this video, Gail Roboz, MD, Weill Cornell Medicine, New York City, NY, discusses the ongoing use of measurable residual ...

MRD Assessment and its Clinical Implications in AML

MRD Assessment and its Clinical Implications in AML

Experts expand on the

Clinical Use of Molecular MRD Testing in AML

Clinical Use of Molecular MRD Testing in AML

Dr Richard Dillon, Department of

Know AML | Measurable Residual Disease

Know AML | Measurable Residual Disease

Measurable residual disease (

Measurable Residual Disease in Acute Myeloid Leukemia MRD in AML

Measurable Residual Disease in Acute Myeloid Leukemia MRD in AML

Prof. Christopher S. Hourigan DM DPhil FACP FRCP Chief, Laboratory of Myeloid Malignancies National Heart, Lung and Blood ...

Translating MRD assessment into routine clinical practice

Translating MRD assessment into routine clinical practice

Sarah Holstein, MD, PhD, University of Nebraska

The clinical application of MRD testing in AML

The clinical application of MRD testing in AML

Here, Michael Heuser, MD, of Hannover

Flow-based MRD versus other MRD detection techniques in AML

Flow-based MRD versus other MRD detection techniques in AML

Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the value of ...

MRD-driven treatment in AML and its role in stem cell transplantation

MRD-driven treatment in AML and its role in stem cell transplantation

In this video, Francesco Buccisano, MD, University of Rome Tor Vergata, Rome, Italy, briefly comments on the role of measurable ...

How can MRD guide treatment of AML?

How can MRD guide treatment of AML?

Christopher Hourigan, MD, DPhil, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, reflects on ...

What is MRD and why is it important in acute myeloid leukemia?

What is MRD and why is it important in acute myeloid leukemia?

During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, KNOW

How do you incorporate MRD into treatment decision-making in clinical practice?

How do you incorporate MRD into treatment decision-making in clinical practice?

During Lymphoma,

Incorporating MRD assessment into clinical decision-making in AML: recent ELN guideline update

Incorporating MRD assessment into clinical decision-making in AML: recent ELN guideline update

In this video, Francesco Buccisano, MD, University of Rome Tor Vergata, Rome, Italy, provides insight into the recently updated ...

Archive: MRD Monitoring in Acute Myeloid Leukemia

Archive: MRD Monitoring in Acute Myeloid Leukemia

Minimal residual disease (

Clinical Cases: MRD in Real-World Clinical Practice

Clinical Cases: MRD in Real-World Clinical Practice

Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '